Table 4.
Univariate and multivariate-adjusted HR and 95% CI for death according to the presence of SAHE
| Outcomes | Events | Crude | Model 1 | Model 2 | Model 3 | ||||
|---|---|---|---|---|---|---|---|---|---|
| N (%) | HR (95%CI) | P Value | HR (95%CI) | P Value | HR (95%CI) | P Value | HR (95%CI) | P Value | |
| At 1 month | 40 (33.1%) | 1.369 (1.129–1.659) | 0.0014 | 1.370 (1.129–1.662) | 0.0014 | 1.096 (0.889–1.353) | 0.3907 | 1.074 (0.866–1.332) | 0.5166 |
| At 3 months | 43 (35.5%) | 1.427 (1.177–1.731) | 0.0003 | 1.428 (1.176–1.734) | 0.0003 | 1.116 (0.903–1.378) | 0.3093 | 1.074 (0.867–1.331) | 0.5153 |
| At 1 year | 52 (43.0%) | 1.651(1.354–2.014) | < 0.0001 | 1.635 (1.340–1.994) | < 0.0001 | 1.343 (1.084–1.664) | 0.0070 | 1.314 (1.057–1.635) | 0.0140 |
Model 1: adjusted for age and gender
Model 2: adjusted for age, gender, hypertension, diabetes mellitus, prior ischemic stroke, dyslipidemia, current drinking, current smoking, admission GCS, admission NIHSS, admission hematoma location, and intraventricular extension
Model 3: adjusted for age, gender, hypertension, diabetes mellitus, prior ischemic stroke, dyslipidemia, current drinking, current smoking, admission GCS, admission NIHSS, admission hematoma location, intraventricular extension, and admission hematoma volume
SAHE extension of hemorrhage into the subarachnoid space, HR hazard ratio, CI confidence interval